Credit Agricole’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.9M | Buy |
155,438
+6,878
| +5% | +$1.35M | 0.07% | 230 |
|
|
2026
Q1 | $29.1M | Sell |
148,560
-3,748
| -2% | -$728K | 0.08% | 196 |
|
|
2025
Q4 | $26.4M | Buy |
152,308
+95,477
| +168% | +$17.4M | 0.06% | 229 |
|
|
2025
Q3 | $10.8M | Buy |
+56,831
| New | +$10.1M | 0.03% | 392 |
|
|
2025
Q1 | $13M | Buy |
76,933
+35,688
| +87% | +$5.86M | 0.04% | 336 |
|
|
2024
Q4 | $6.22M | Buy |
41,245
+12,933
| +46% | +$2.01M | 0.02% | 507 |
|
|
2024
Q3 | $4.4M | Buy |
28,312
+1,835
| +7% | +$274K | 0.02% | 449 |
|
|
2024
Q2 | $3.62M | Buy |
26,477
+19,656
| +288% | +$2.69M | 0.02% | 443 |
|
|
2024
Q1 | $859K | Buy |
6,821
+3,640
| +114% | +$472K | 0.01% | 585 |
|
|
2023
Q4 | $439K | Buy |
3,181
+2,126
| +202% | +$280K | 0.01% | 590 |
|
|
2023
Q3 | $129K | Buy |
+1,055
| New | +$141K | ﹤0.01% | 669 |
|
|
2022
Q1 | – | Sell |
-821
| Closed | -$142K | – | 720 |
|
|
2021
Q4 | $142K | Sell |
821
-191
| -19% | -$29.1K | ﹤0.01% | 441 |
|
|
2021
Q3 | $147K | Buy |
1,012
+34
| +3% | +$4.97K | ﹤0.01% | 410 |
|
|
2021
Q2 | $129K | Buy |
978
+388
| +66% | +$50.8K | ﹤0.01% | 405 |
|
|
2021
Q1 | $76K | Buy |
590
+274
| +87% | +$33.8K | ﹤0.01% | 411 |
|
|
2020
Q4 | $38K | Buy |
316
+66
| +26% | +$8.05K | ﹤0.01% | 419 |
|
|
2020
Q3 | $29K | Hold |
250
| – | – | ﹤0.01% | 399 |
|
|
2020
Q2 | $28K | Hold |
250
| – | – | ﹤0.01% | 354 |
|
|
2020
Q1 | $20K | Hold |
250
| – | – | ﹤0.01% | 382 |
|
|
2019
Q4 | $27K | Hold |
250
| – | – | ﹤0.01% | 344 |
|
|
2019
Q3 | $27K | Hold |
250
| – | – | ﹤0.01% | 407 |
|
|
2019
Q2 | $25K | Hold |
250
| – | – | ﹤0.01% | 410 |
|
|
2019
Q1 | $22K | Buy |
+250
| New | +$21.7K | ﹤0.01% | 415 |
|
|
2017
Q4 | – | Sell |
-133,310
| Closed | -$12.5M | – | 558 |
|
|
2017
Q3 | $12.5M | Sell |
133,310
-3,621
| -3% | -$384K | 0.04% | 414 |
|
|
2017
Q2 | $15.2M | Buy |
136,931
+870
| +0.6% | +$92K | 0.05% | 378 |
|
|
2017
Q1 | $13.4M | Sell |
136,061
-22,258
| -14% | -$2.12M | 0.04% | 459 |
|
|
2016
Q4 | $14.5M | Buy |
158,319
+11,862
| +8% | +$1.02M | 0.05% | 394 |
|
|
2016
Q3 | $12.4M | Buy |
146,457
+72,559
| +98% | +$6.09M | 0.04% | 421 |
|
|
2016
Q2 | $6.01M | Buy |
73,898
+16,173
| +28% | +$1.23M | 0.02% | 578 |
|
|
2016
Q1 | $4.13M | Buy |
57,725
+6,770
| +13% | +$454K | 0.02% | 611 |
|
|
2015
Q4 | $3.63M | Buy |
50,955
+19,291
| +61% | +$1.3M | 0.02% | 649 |
|
|
2015
Q3 | $1.95M | Buy |
31,664
+1,600
| +5% | +$112K | 0.01% | 826 |
|
|
2015
Q2 | $2.18M | Sell |
30,064
-6,801
| -18% | -$502K | 0.01% | 827 |
|
|
2015
Q1 | $2.83M | Sell |
36,865
-211,169
| -85% | -$15.1M | 0.01% | 770 |
|
|
2014
Q4 | $16.6M | Buy |
248,034
+140,597
| +131% | +$8.87M | 0.07% | 313 |
|
|
2014
Q3 | $6.52M | Sell |
107,437
-6,242
| -5% | -$385K | 0.03% | 546 |
|
|
2014
Q2 | $6.67M | Sell |
113,679
-23,484
| -17% | -$1.38M | 0.03% | 548 |
|
|
2014
Q1 | $7.94M | Buy |
137,163
+90,391
| +193% | +$4.84M | 0.03% | 500 |
|
|
2013
Q4 | $2.5M | Sell |
46,772
-375,863
| -89% | -$22.3M | 0.01% | 802 |
|
|
2013
Q3 | $26.1M | Buy |
+422,635
| New | +$25.3M | 0.11% | 227 |
|
Other funds holding DGX
EIG
Credit Agricole's DGX Position: Q2 2026 in Review
Credit Agricole increased its Quest Diagnostics (DGX) stake by 4.6% in Q2 2026, buying an estimated $1.35M and bringing the position to 155,438 shares worth $32.9M. The position accounts for 0.07% of the portfolio, ranked #230.
Credit Agricole first reported a position in DGX in Q3 2013 and has held it in 40 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Credit Agricole held 155,438 shares of Quest Diagnostics worth $32.9M as of Q2 2026.
- Credit Agricole bought 6,878 Quest Diagnostics shares in Q2 2026, an estimated $1.35M.
- Quest Diagnostics made up 0.07% of Credit Agricole's portfolio in Q2 2026, its #230 holding.
- Credit Agricole first reported a position in Quest Diagnostics in Q3 2013 and has held it in 40 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.